002252.SZ
上海莱士
SZSE · Healthcare · C 制造业 · CN
CNY 4.81
−0.21%Year over year
Reported trailing growth
- Revenue
- -15.7%
- EBITDA
- —
- EBIT
- -33.6%
- EPS
- -33.5%
- Free cash flow
- -69.3%
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -50.3%
- EBITDA
- -25.1%
- EPS
- -10.2%
Three-year CAGR
- Revenue
- +3.8%
- EBITDA
- -4.5%
- EBIT
- -5.7%
- Net income
- -5.7%
- EPS
- -5.0%
- Free cash flow
- +20.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026